FDA Diagnostics Office Seeks Bigger Role In Personalized Medicine
This article was originally published in The Gray Sheet
Executive Summary
FDA officials that regulate lab tests don't think they have been active enough in the policy debate over the future of personalized medicine; but, they say, that is about to change